Moving Successful Virus-specific T-cell Therapy for Hematopoietic Stem Cell Recipients to Late Phase Clinical Trials

Mol Ther Nucleic Acids. 2012 Nov 13;1(11):e55. doi: 10.1038/mtna.2012.49.
No abstract available